Status message

Active context: kki_bg_colors_yellow

An Open-Label Extension Study of the Long-Term Safety, Tolerability and Efficacy of Drisapersen in US And Canadian Subjects with Duchenne Muscular Dystrophy

This is a phase III, multicenter, open-label, uncontrolled extension study in male subjects with DMD open to eligible US who previously participated in a GSK drisapersen study.